<!–欲查看中文简体版的作者指南，请点击此处。 View a Chinese translation of this page.–> Gut is a leading international journal in gastroenterology and hepatology and has an established reputation for publishing first class clinical research of the alimentary tract, the liver, biliary tree and pancreas. Gut delivers up-to-date, authoritative, clinically oriented coverage in all areas of gastroenterology and hepatology. Regular features include articles describing novel mechanisms of disease and new management strategies, both diagnostic and therapeutic, likely to impact on clinical practice within the foreseeable future by leading authorities. Gut will consider very high quality papers under the Fast Track Review scheme. This scheme relies on a dedicated group of top class reviewers to deliver a final decision on reviewed manuscripts within seven days. The scheme is free to authors; the journal donates money to charity for every completed manuscript.
Gut adheres to the highest standards concerning its editorial policies on publication ethics, scientific misconduct, consent and peer review criteria. To view all BMJ Journal policies please refer to the BMJ Author Hub policies page.
Plan S compliance
Gut is a Plan S compliant Transformative Journal. Transformative Journals are one of the compliance routes offered by cOAlition S funders, such as Wellcome, WHO and UKRI. Find out more about Transformative Journals and Plan S compliance on our Author Hub.
Copyright and authors’ rights
Articles are published under an exclusive licence or non-exclusive licence for UK Crown employees or where BMJ has agreed CC BY applies. For US Federal Government officers or employees acting as part of their official duties, the terms are as stated in accordance with our licence terms. Authors or their employers retain copyright. Open access articles can be reused under the terms of the relevant Creative Commons licence to facilitate reuse of the content; please refer to the Gut Author Licence for the applicable Creative Commons licences. More information on copyright and authors’ rights.
When publishing in Gut, authors choose between three licence types – exclusive licence granted to BMJ, CC-BY-NC and CC-BY (Creative Commons open access licences require payment of an article processing charge). As an author you may wish to post your article in an institutional or subject repository, or on a scientific social sharing network. You may also link your published article to your preprint (if applicable). What you can do with your article, without seeking permission, depends on the licence you have chosen and the version of your article. Please refer to the BMJ author self archiving and permissions policies page for more information.
Preprints foster openness, accessibility and collaboration by allowing authors to make their findings immediately available to the research community and receive feedback on an article before it is submitted to a journal for formal publication. BMJ fully supports and encourages the archiving of preprints in any recognised, not-for-profit server such as medRxiv. BMJ does not consider the posting of an article in a dedicated preprint repository to be prior publication.
Preprints are reports of work that have not been peer-reviewed; Preprints should therefore not be used to guide clinical practice, health-related behaviour or health policy. For more information, please refer to our Preprint policy page.
Peer review process
Articles submitted to Gut are subject to peer review. In most instances we aim for two external opinions (and often additional statistical assessment) for reasons of fairness and science. The journal is not prepared to compromise on this stance. The journal operates single anonymised peer review whereby the names of the reviewers are hidden from the author; Manuscripts authored by a member of a journal’s editorial team are independently peer reviewed; an editor will have no input or influence on the peer review process or publication decision for their own article. For more information on what to expect during the peer review process please refer to BMJ Author Hub – the peer review process. BMJ requests that all reviewers adhere to a set of basic principles and standards during the peer-review process in research publication; these are based on the COPE Ethical Guidelines for Peer Reviewers. Please refer to our peer review terms and conditions policy page.
BMJ is committed to transparency. Every article we publish includes a description of its provenance (commissioned or not commissioned) and whether it was internally or externally peer reviewed. During the submission process, authors must not suggest reviewers who are current or recent colleagues of themselves or their co-authors. For more information about suggesting reviewers please visit our Author Hub. Plagiarism is the appropriation of the language, ideas or thoughts of another without crediting their true source and representation of them as one’s own original work. BMJ is a member of CrossCheck by CrossRef and iThenticate. iThenticate is a plagiarism screening service that verifies the originality of content submitted before publication. BMJ runs manuscripts through iThenticate during the peer review process. Authors, researchers and freelancers can also use iThenticate to screen their work before submission by visiting www.ithenticate.com.
Article transfer service
BMJ and the British Society of Gastroenterology are committed to ensuring that good quality research is published. Our article transfer service helps authors find the best journal for their research while providing an easy and smooth publication process. As part of this service, once authors agree to transfer their manuscript all versions, supplementary files and peer reviewer comments are automatically transferred, without the need to resubmit or reformat. Authors who submit to Gut and whose work is rejected on the grounds of priority will be offered the option of transferring to Frontline Gastroenterology or BMJ Open Gastroenterology. Frontline Gastroenterology is the education and practice companion journal to Gut. It is indexed by Web of Science Core Collection: Emerging Sources Citation Index; PubMed Central; Embase (Excerpta Medica); CINAHL; Google Scholar, and covers the fields of gastroenterology, hepatology and clinical nutrition. The journal publishes articles in the domains of clinical quality, patient experience, service provision and medical education. Find out more about Frontline Gastroenterology.
BMJ Open Gastroenterology is the open access companion journal to Gut. It is indexed by Web of Science: Emerging Sources Citation Index, MEDLINE, PubMed Central, Embase (Excerpta Medica), DOAJ, Google Scholar, and covers all disciplines and therapeutic areas of gastroenterology and hepatology. The journal publishes original articles considered by peer reviewers to be coherent and technically sound, ensuring that the latest research is disseminated rapidly to a global audience. Find out more about BMJ Open Gastroenterology. Please note that the article transfer service does not guarantee acceptance but you should receive a quicker initial decision on your manuscript. Contact the Transfer Editor at firstname.lastname@example.org
Article processing charges
During submission, authors can choose to have their article published open access for 3,700 GBP (exclusive of VAT for UK and EU authors). Publishing open access has multiple benefits including wider reach, faster impact and increased citation and usage. Authors can also choose to publish their article in colour for the print edition – instead of the default option of black and white – for 415 GBP. There are no submission, page or online-only colour figure charges.
Waivers and discounts
If authors choose to publish their article open access, an APC waiver may be available. Before applying for an APC waiver please consider: (1) Does your institution have an open access agreement with BMJ? If it does, then this may cover all or part of the APC for your article. Check BMJ’s open access agreements page to find out whether your institution is a member and what discounts you may be entitled to. (2) Have you received funding from a funder with an open access mandate or policy that covers paying APCs? If so, BMJ expects that the APC will be paid in full. If neither (1) nor (2) above apply then consider (3) Are all the authors of your article based in low-income countries*? If so, you are eligible to apply for a full or partial waiver from BMJ. Visit our author hub to learn more about our waivers policy and how to request one. Please note that regardless of the funding situation, authors can still choose to publish with us at no cost, and articles will be made available to our subscribers. *This list is reviewed annually and is based upon HINARI Core Offer Groups A and B, and the World Bank Country and Lending Groups.
Gut mandates ORCID iDs for the submitting author at the time of article submission; co-authors and reviewers are strongly encouraged to also connect their ScholarOne accounts to ORCID. We strongly believe that the increased use and integration of ORCID iDs will be beneficial for the whole research community. Please find more information about ORCID and BMJ’s policy on our Author Hub.
Gut adheres to BMJ’s Tier 3 data policy. We strongly encourage that data generated by your research that supports your article be made available as soon as possible, wherever legally and ethically possible. All research articles must contain a Data Availability Statement. For more information and FAQs, please see BMJ’s full Data Sharing Policy page.
Reporting patient and public involvement in research
BMJ encourages active patient and public involvement in clinical research as part of its patient and public partnership strategy. To support co-production of research we request that authors provide a Patient and Public Involvement statement in the methods section of their papers, under the subheading ‘Patient and public involvement’. We appreciate that patient and public involvement is relatively new and may not be feasible or appropriate for all papers. We therefore continue to consider papers where patients were not involved. The Patient and Public Involvement statement should provide a brief response to the following questions, tailored as appropriate for the study design reported (please find example statements here):
- At what stage in the research process were patients/the public first involved in the research and how?
- How were the research question(s) and outcome measures developed and informed by their priorities, experience, and preferences?
- How were patients/the public involved in the design of this study?
- How were they involved in the recruitment to and conduct of the study?
- Were they asked to assess the burden of the intervention and time required to participate in the research?
- How were (or will) they be involved in your plans to disseminate the study results to participants and relevant wider patient communities (e.g. by choosing what information/results to share, when, and in what format)?
A rapid response is a moderated but not peer reviewed online response to a published article in Gut; it will not receive a DOI and will not be indexed. Find out more about responses and how to submit a response.
Please review the below article type specifications including the required article lengths, illustrations, table limits and reference counts. The word count excludes the title page, abstract, tables, acknowledgements, contributions and references. Manuscripts should be as succinct as possible For further support when making your submission please refer to the resources available on the BMJ Author Hub. Here you will find information on writing and formatting your research through to the peer review process and promoting your paper. You may also wish to use the language editing and translation services provided by BMJ Author Services. If your article is accepted, visit our “Promoting Your Paper” page on the BMJ Author Hub for suggestions on how to maximise your article’s reach.
Original research should be research articles reporting original data (eg, controlled trials and intervention studies). Research reviews that systematically synthesise evidence (e.g. Systematic reviews, Meta-analysis, Scoping reviews, Mixed methods reviews, etc) should be submitted as Original research. Please include the research type in your title to make the nature of your study clear. Following the lead of The BMJ and its patient partnership strategy, Gut is encouraging active patient involvement in setting the research agenda. As such, we require authors of Research Articles to add a Patient and Public Involvement statement in the Methods section.
Word count: up to 4,000 Structured abstract: up to 250 words: ‘Objective’, ‘Design’, ‘Results’, ‘Conclusion’ Tables/ Illustrations: Figures are not limited, but must be thoroughly justified. References: limited to those critical and relevant to the manuscript (around 50) Please include the key messages of your article after your abstract using the following headings. This section should be no more than 3-5 sentences and should be distinct from the abstract; be succinct, specific and accurate.
- What is already known on this topic – summarise the state of scientific knowledge on this subject before you did your study and why this study needed to be done
- What this study adds – summarise what we now know as a result of this study that we did not know before
- How this study might affect research, practice or policy – summarise the implications of this study
Gut rarely publishes Case reports unless they illustrate a significant advance in our understanding of disease aetiology or pathogenetic mechanisms.
Word count: up to 2,000 Structured abstract: up to 200 words Tables/Illustrations: up to 2 References: up to 15
Letters should be related to a recent article published in Gut (i.e within the previous two years). Original data may be included if it is relevant and gives added weight to the comment on the previously published article.
Word count: up to 600 Tables/Illustrations: up to 2 References: up to 10
GI snapshots report unusual images that make an educational point. Since the aim of these articles is to stimulate the reader to think about the case, the title should be ambiguous and not give away the final diagnosis immediately (e.g. "Recurrent vomiting in 90 year old female"). GI snapshots have two parts:
- Introduction - a brief clinical introduction to a case (maximum 200 words) followed by an image and a question designed to stimulate the reader to think about what the image shows. The legend should not indicate the diagnosis but should simply describe the nature of the image (e.g. 'endoscopic view of second part of duodenum').
- Answer - appears later in the issue (maximum 200 words) outlines a brief description of the key diagnostic features of the image, the outcome, and a teaching point. GI snapshots will not include more than 5 references.
The quality of the image must be at least 300dpi and in TIFF, JPEG, GIF or EPS format. Videos are also welcome and should be in .mov, .avi, or .mpeg format. If your GI snapshot is rejected from Gut you can transfer your article to Frontline Gastroenterology as an Inside view ask the Editorial Assistant for more information: email@example.com.
Recent advances in basic science/recent advances in clinical practice
Recent advances are mostly commissioned but Gut does accept unsolicited submissions too. Recent advances in basic science are aimed at bringing busy clinicians up to date with recent advances in the basic science field, which are likely to underlie changes in clinical practice in the foreseeable future.
Word count: 4000 to 5000 Tables/Illustrations: 5 or 6 figures, or clear simple diagrams References: 30 to 90 We would like you to list key messages, as well as 5 or 6 bullet points for emphasis. Recent advances in clinical practice are aimed at bringing busy clinicians up to date in areas where there have been important advances that are starting to influence clinical practice.
The BMJ Publishing Group journals are willing to consider publishing supplements to
- The journal editor, an editorial board member or a learned society may wish to organise a meeting, sponsorship may be sought and the proceedings published as a supplement.
- The journal editor, editorial board member or learned society may wish to commission a supplement on a particular theme or topic. Again, sponsorship may be sought.
- The BMJPG itself may have proposals for supplements where sponsorship may be necessary.
- A sponsoring organisation, often a pharmaceutical company or a charitable foundation, that wishes to arrange a meeting, the proceedings of which will be published as a supplement.
For further information on criteria that must be fulfilled, download the supplements guidelines. When contacting us regarding a potential supplement, please include as much of the information below as possible.
- Journal in which you would like the supplement published
- Title of supplement and/or meeting on which it is based
- Date of meeting on which it is based
- Proposed table of contents with provisional article titles and proposed authors
- An indication of whether authors have agreed to participate
- Sponsor information including any relevant deadlines
- An indication of the expected length of each paper Guest Editor proposals if appropriate